Assessment: Transcranial Doppler ultrasonography: [RETIRED]: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology*

Clicks: 280
ID: 267703
2004
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #21 of 76 articles by views in Neurology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Objective: To review the use of transcranial Doppler ultrasonography (TCD) and transcranial color-coded sonography (TCCS) for diagnosis. Methods: The authors searched the literature for evidence of 1) if TCD provides useful information in specific clinical settings; 2) if using this information improves clinical decision making, as reflected by improved patient outcomes; and 3) if TCD is preferable to other diagnostic tests in these clinical situations. Results: TCD is of established value in the screening of children aged 2 to 16 years with sickle cell disease for stroke risk (Type A, Class I) and the detection and monitoring of angiographic vasospasm after spontaneous subarachnoid hemorrhage (Type A, Class I to II). TCD and TCCS provide important information and may have value for detection of intracranial steno-occlusive disease (Type B, Class II to III), vasomotor reactivity testing (Type B, Class II to III), detection of cerebral circulatory arrest/brain death (Type A, Class II), monitoring carotid endarterectomy (Type B, Class II to III), monitoring cerebral thrombolysis (Type B, Class II to III), and monitoring coronary artery bypass graft operations (Type B to C, Class II to III). Contrast-enhanced TCD/TCCS can also provide useful information in right-to-left cardiac/extracardiac shunts (Type A, Class II), intracranial occlusive disease (Type B, Class II to IV), and hemorrhagic cerebrovascular disease (Type B, Class II to IV), although other techniques may be preferable in these settings.
Reference Key
sloan2004neurologyassessment: Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors M. A. Sloan;A. V. Alexandrov;C. H. Tegeler;M. P. Spencer;L. R. Caplan;E. Feldmann;L. R. Wechsler;D. W. Newell;C. R. Gomez;V. L. Babikian;D. Lefkowitz;R. S. Goldman;C. Armon;C. Y. Hsu;D. S. Goodin;M. A. Sloan;A. V. Alexandrov;C. H. Tegeler;M. P. Spencer;L. R. Caplan;E. Feldmann;L. R. Wechsler;D. W. Newell;C. R. Gomez;V. L. Babikian;D. Lefkowitz;R. S. Goldman;C. Armon;C. Y. Hsu;D. S. Goodin;
Journal Neurology
Year 2004
DOI
10.1212/WNL.62.9.1468
URL
https://doi.org/10.1212/wnl.62.9.1468##abstract-1
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.